Request Your Free White Paper Now:

"PEA - An easier approach to utilizing the Endocannabinoid System"

Explore the naturally occurring CBD alternative.

Levagen®, also known as Palmitoylethanolamide (PEA), is a naturally occurring fatty acid amide that exerts benefits such as supporting a balanced inflammatory response through the endocannabinoid system, more specifically, by increasing levels of anandamide (AEA) which has been referred to, as the “bliss molecule.”

As a result, PEA can serve to target pathways similar to that of cannabidiol (CBD) while simultaneously avoiding the legal and regulatory hurdles that CBD products face on the market today. 

The benefits of PEA can be limited by its bioavailability, but a novel technology known as LipiSperse® has been leveraged to create Levagen® +, with up to 1.8 times the bioavailability of standard PEA. 

Formulators can rest assured that Levagen®+ can provide benefits that are in demand by consumers interested in CBD but with the clinical substantiation and regulatory status to prime your product for success. 

Offered Free by: Gencor
See All Resources from: Gencor